Letters

Management of cutaneous T cell lymphoma

BMJ 1994; 308 doi: https://doi.org/10.1136/bmj.308.6932.858b (Published 26 March 1994) Cite this as: BMJ 1994;308:858
  1. Eileen J Parry,
  2. Rona M Mackie
  1. University Department of Dermatology, Western Infirmary, Glasgow G11 6NT.

    Editor,--We agree with Paul A Bunn that multicentre prospective randomised trials in patients with properly staged cutaneous T cell lymphoma are urgently needed to define the optimal topical or systemic treatment.1 We also agree with his comments regarding the combination of psoralens and ultraviolet A treatment and interferon, which may produce a higher complete response rate than either agent used singly; we have useful experience of this.

    We have successfully managed an 89 year old woman with tumour stage cutaneous T cell lymphoma with this combination. …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe